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Abstract
It is well known that the mu-opioid receptor (MOR) plays an important role in the rewarding properties of ethanol. However,
it is less clear how chronic ethanol consumption affects MOR signaling. Here, we demonstrate that rats with prolonged
voluntary ethanol consumption develop antinociceptive tolerance to opioids. Signaling through the MOR is controlled at
many levels, including via the process of endocytosis. Importantly, agonists at the MOR that promote receptor endocytosis,
such as the endogenous peptides enkephalin and b-endorphin, show a reduced propensity to promote antinociceptive
tolerance than do agonists, like morphine, which do not promote receptor endocytosis. These observations led us to
examine whether chronic ethanol consumption produced opioid tolerance by interfering with MOR endocytosis. Indeed,
here we show that chronic ethanol consumption inhibits the endocytosis of MOR in response to opioid peptide. This loss of
endocytosis was accompanied by a dramatic decrease in G protein coupled receptor kinase 2 (GRK2) protein levels after
chronic drinking, suggesting that loss of this component of the trafficking machinery could be a mechanism by which
endocytosis is lost. We also found that MOR coupling to G-protein was decreased in ethanol-drinking rats, providing a
functional explanation for loss of opioid antinociception. Together, these results suggest that chronic ethanol drinking alters
the ability of MOR to endocytose in response to opioid peptides, and consequently, promotes tolerance to the effects of
opioids.
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Introduction
The mu opioid receptor (MOR) has long been proposed to
contribute to alcohol consumption [1,2]. Indeed, blocking the
MOR with an opioid antagonist significantly reduces ethanol
consumption in both animal models (see for example [3]) and,
with variable efficacy, in humans [4–7]. In further support of a
role for MOR in drinking, animals with higher levels of MOR in
certain brain regions drink more alcohol compared to animals
with lower MOR levels [8,9]. Moreover, animals with an RNAi
knock-down of MOR [10], or a genetic disruption of MOR, show
reduced drinking and reward to ethanol [11,12]. Taken together,
these studies strongly implicate the MOR in the mechanisms
underlying alcohol consumption and, potentially, its abuse.
Despite the clear role of MOR in modulating ethanol
consumption and reward, few studies have examined the effects
of drinking on signal transduction from the MOR. Importantly,
ethanol has been shown to increase release of endogenous opioids
in brain regions key to the rewarding properties of drugs of abuse
[13–15]. This would be expected to increase signal transduction
through MOR, in effect signaling the presence of ethanol. By
extension, opioid antagonists, such as naltrexone, are thought to
decrease ethanol consumption because they block the actions of
these endogenously released opioids. On the other hand, chronic
ethanol consumption appears to decrease the functional respon-
siveness of the MOR [16–18], suggesting that adaptations can
occur during chronic ethanol exposure that make the MOR less
sensitive to the same dose of opioid. However, the mechanisms
that mediate these decreases in the sensitivity of MOR responses
are not known.
After activation by endogenous opioids, signaling from the
MOR is regulated by many processes, including desensitization by
G protein coupled receptor kinases (GRK) and arrestins,
endocytosis of the receptor [19], and recycling and resensitization
of the receptor [20]. This cascade of events serves to carefully
titrate signal transduction from the receptor and is ideally suited to
monitor the presence of ligands, such as the endogenous opioid
peptides that are released in a pulsatile manner. Agonist ligands
such as morphine that do not promote desensitization/endocyto-
sis/resensitization of the MOR, have been shown to facilitate
homeostatic adaptive responses in signal transduction that
manifest as reduced responsiveness to the presence of opioid
ligands at the cellular level, and as antinociceptive tolerance at the
behavioral level (for review see [21]). Here, we found that chronic
voluntary consumption of ethanol causes a downregulation of
GRK and prevents endocytosis of the MOR in response to opioid
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19372peptide ligand. As a consequence, rats consuming ethanol show
tolerance to the antinociceptive effects of opioids.
Materials and Methods
Ethics statement
All experiments with vertebrate animals were approved by the
Institutional Animal Care and Use Committee at Ernest Gallo
Clinic and Research Center, University of California, San
Francisco, protocol number 08.06.173 and were in accordance
with National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
Animals and drugs
Male Wistar rats (200–220 g) were purchased from Charles
River Laboratories (Wilmington, MA) and housed individually in
a temperature controlled environment (2262uC) with a 12-hour
light/dark cycle. Rats were given 1 week to acclimatize to the new
housing conditions with food and water available ad libitum before
being entered into the study. All experiments with vertebrate
animals were approved by the Institutional Animal Care and Use
Committee at Ernest Gallo Clinic and Research Center,
University of California, San Francisco, and were in accordance
with National Institutes of Health Guide for the Care and Use of
Laboratory Animals. [
3H]–Ala
2-MePhe
4-Gly-ol
5 enkephalin
(DAMGO) (50 Ci/mmol) was purchased from PerkinElmer Life
Science (Boston, MA, USA). Morphine sulfate was obtained from
Sigma Chemical (St. Louis, MO, USA). DAMGO was purchased
from Tocris Cookson, Inc (UK). The drugs were dissolved in
physiological saline and injected intrathecally (i.t.) in a volume of
5 ml/rat as previously described [22,23].
Ethanol Drinking Procedure
The intermittent access 20% ethanol two-bottle choice drinking
paradigm was used as previously described with minor modifica-
tions [24]. In brief, each week rats were given 24 hour access to
ethanol (20% v/v) and water in 100-ml graduated glass cylinders
with stainless-steel drinking spouts on Monday, Wednesday, and
Friday. On Tuesday and Thursday the ethanol bottle was replaced
with a second water bottle that was available for 24 hours. The
rats had unlimited access to water over the weekend after the 24-
hour ethanol drinking measurements were taken on Saturday
morning. Bottles were weighed to the nearest gram.
Antinociception assessment
Drugs were administered i.t. in a volume of 5 ml/rat as
previously described [22,23].
Antinociception was tested using the radiant heat tail-flick
procedure 30 minutes after i.t. drug administration. The light
intensity was adjusted to achieve baseline (drug free) latencies of 3
to 4 seconds and a maximum latency of 10 seconds was set as the
cut-off time to minimize damage to the tail. Data are reported as
maximal possible effect (MPE), calculated as 100% 6 [(drug
response time - basal response time)/(cutoff time - basal response
time)].
Immunohistochemistry
Rats were anesthetized with isofluorane and perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer immediately follow-
ing the tail-flick test. The lumber segment of the spinal cord was
dissected out, post-fixed overnight, and then transferred to a 30%
sucrose buffer solution. Sagittal sections (30 mm) were cut on a
cryostat at 220uC, pre-incubated in PBT solution (0.1 M
phosphate buffer, 0.2% BSA, 0.2% Triton X-100) for 30 minutes,
blocked in 5% normal goat serum in PBT solution for another 30
minutes, and then incubated overnight at 4uC with rabbit anti-
MOR antibody (1:2000, ImmunoStar, Inc, Hudson, WI, USA)
and either mouse anti-NeuN antibody (1:5000, Chemicon
International, Temecula, CA, USA) or mouse anti-Rab5
(1:1000, Abcam Inc., Cambridge, MA, USA). Sections were then
extensively washed with PBT and incubated for 2 hours at room
temperature with Alexa 488-conjugated goat anti-rabbit antibody
and Alexa 546-conjugated goat anti-mouse antibody (Invitrogen,
Carlsbad, CA, USA), both at 2 mg/ml. The sections were then
washed and mounted on slides. MOR distribution was examined
with a Zeiss confocal microscope using a 636 oil immersion
objective. The intracellular MOR vesicles were counted using
ImageJ software by an investigator blind to treatment. The plasma
membrane was first selected as the border of the measurement.
The threshold and the size of vesicles to be measured were equal
among the different treatment groups. Ninety neurons taken from
2 to 5 rats per group were quantified.
GRK2 Immunoblot
Rats were sacrificed by decapitation after 4 or 8 weeks of water
or ethanol drinking, and the lumber segments of spinal cord were
quickly dissected out on ice. Tissue was homogenized in ice-cold
buffer [10 mM Tris-HCl and 5 mM EDTA (pH 7.4)] containing a
protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN).
The homogenates were stored at 280uC until use. Proteins were
solubilized by boiling in 2% SDS containing 50 mM dithiothreitol,
resolved by 4–12% SDS-PAGE (15 mg/lane) and transferred to
PVDF membranes. The membranes were incubated in blocking
buffer (5% nonfat dry milk in 20 mM Tris-HCl containing 0.1%
Tween-20, 140 mM NaCl pH 7.4) for 1 h at room temperature
and then incubated in blocking buffer with monoclonal anti-
GRK2 antibody (1:5,000, Santa Cruz Technology, Inc., Santa
Cruz, CA, USA), and monoclonal anti-b actin antibody (1:10,000,
Sigma, St. Louis, MO) overnight at 4uC. After extensive washing
with Tris-buffered saline containing 0.1% Tween-20, the mem-
branes were incubated with horseradish peroxidase-conjugated
goat anti-mouse antibody at a dilution of 1:10,000 for the GRK2
and 1:20,000 for the b actin for 1 h at room temperature in
blocking buffer. Following several washes with Tris-buffered saline
containing 0.1% Tween-20, proteins were visualized with
enhanced chemiluminescence. Densitometric quantification of
immunoreactive bands was performed using Scion Image software
(Scion Corporation, Frederick, MD USA). The relative GRK2
protein levels were obtained by normalizing the anti-b-actin
immunoblot against the corresponding GRK2 immunoblot from
the same membrane and are expressed as a percentage relative to
the control group. The differences between control and ethanol
drinking groups were analyzed by a Student t test.
Tissue section preparation for autoradiography
Rats were sacrificed by decapitation. Brain and the lumber
segment of spinal cord were quickly dissected out on ice and were
frozen in isopentane on dry ice and stored at 280uC. Coronal
sections (16 mm) were cut on a cryostat at 220uC and thaw-
mounted onto gelatin-subbed slides. The slides were dried and
stored desiccated at 280uC until use.
[
3H]DAMGO autoradiography
Sections (prepared as above) were preincubated in assay buffer
(50 mmol/l Tris- HCl, pH 7.4) for 30 minutes and then incubated
in the same buffer containing [
3H]DAMGO (4 nM) for 60 min at
room temperature as previously described [25]. Nonspecific
binding was defined as the [
3H]DAMGO signal obtained in the
Alcohol Affects Mu Opioid Receptor Trafficking
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After incubation, slides were rinsed twice in cold 50 mM Tris-HCl
buffer, pH 7.4, and once in deionized water, dried and exposed to
Kodak BioMax light film with an intensifying screen for 3 weeks.
Slides containing PAG sections were exposed for 4 weeks. The
films were developed using a medical film processor (SRX-101A,
Konica Minocta). At least 4 sections from a minimum of 3 animals
per group were quantified.
DAMGO-activated [
35S]GTPcS autoradiography
Sections were pre-incubated in assay buffer (50 mM Tris-HCl,
3 mM MgCl, 0.2 mM EGTA, 100 mM NaCl, pH 7.4) at room
temperature for 10 minutes and then incubated with 2 mM GDP
in assay buffer for 10 minutes at room temperature as previously
described [26]. Sections were then incubated for 90 min at room
temperature in assay buffer containing [
35S]GTPcS (0.05 nM) and
2 mM GDP, with and without the agonist DAMGO (2 mM). After
incubation, slides were rinsed twice in cold 50 mM Tris-HCl
buffer, pH 7.4, and once in deionized water, dried, and exposed to
Kodak BioMax light film for 3 days. At least 4 sections from a
minimum of 3 animals per group were quantified.
Statistics and image analysis
The antinociceptive effects of the drugs between treatment days
or between water and ethanol drinking rats were analyzed by a
Student t test. The regional neuroanatomy of the rat was
determined using the atlas of Paxinos and Watson [27]. Brain
areas in the autoradiograms and spinal cord were quantified using
Scion Image software (Scion Corporation, Frederick, MD, USA).
For [
3H]DAMGO autoradiography, optical densities were
converted into fmol/mg tissue for quantification of MOR sites
according to a [
3H] microscale standard (GE Healthcare UK
Limited). For DAMGO-activated [
35S]GTPcS autoradiography,
data were expressed as % activation, where % activation =
[(activated – basal)/basal] X 100. The data are expressed as mean
6 S.E.M. and were compared using a Student t test. The
comparisons of intracellular vesicle counts among groups were
analyzed with a one-way ANOVA followed by a Newman-Keuls
post-test. Results were considered significant if p#0.05. All
statistical analyses were done using GraphPad Prism Software
(San Diego, CA, USA).
Results
Ethanol drinking induces tolerance to exogenous opioids
We and others have reported that ligands that promote
endocytosis of the MOR produce reduced antinociceptive
tolerance compared to morphine, which does not promote
MOR endocytosis. These results have led us to hypothesize that
endocytosis protects against the development of tolerance. To
further examine this hypothesis, we tested the ability of equi-
antinociceptive morphine and DAMGO, a hydrolysis-resistant
form of one of the endogenous ligands at the MOR, to produce
antinociceptive tolerance.
Rats were injected with intrathecal (i.t.) morphine or DAMGO
twice daily for 4 days and were tested on days 1 and 5 for their
antinociceptive response to these two drugs. Rats developed
significant antinociceptive tolerance to morphine, while DAMGO
remained as effective on day 5 as day 1 (Figure S1A).
We next examined whether chronic ethanol drinking would
alter the antinociception produced by opioid drugs. Rats were
trained to drink ethanol in an intermittent-access paradigm [24] in
which they were given access to 20% ethanol for three 24-hour
sessions per week. During the first 5 to 6 drinking sessions rats
escalated their consumption, reaching a stable level of drinking by
session 14 (Figure 1A). The antinociceptive effects of the opioid
peptide DAMGO (i.t, 1 nmol/rat) was assessed at two time points:
4 and 8 weeks after initiation of alcohol drinking. After 8 weeks of
drinking, rats had developed significant antinociceptive tolerance
to DAMGO (Figure 1B). Not all paradigms that produce
antinociceptive tolerance produce cross tolerance to multiple
opioid drugs [28–31]. However, we found that chronic voluntary
ethanol consumption produced tolerance to not only DAMGO
but also morphine (i.t. 20 nmol/rat, Figure S1B). These decreases
in antinociception were not due simply to increased age, since
water drinking animals did not develop antinociceptive tolerance
to opioid drug (Figure 1B, S1B). Ethanol itself can produce
antinociceptive effects [32,33], at least some of which are mediated
by the MOR [34]. However, a direct effect of ethanol on
DAMGO-mediated antinociception in these drinking rats is
unlikely since DAMGO antinociception was tested 24 hours after
their last ethanol exposure, and blood alcohol concentration at
that time was no different than that in water drinking group.
The effects of chronic ethanol drinking on MOR levels
It was possible that the reduction in the antinociceptive effect of
i.t. DAMGO was a consequence of MOR down-regulation. To
Figure 1. The antinociceptive effects of intrathecal (i.t.)
DAMGO following chronic ethanol consumption. (A) Rats were
given intermittent access to 20% ethanol (three 24-hour sessions per
week). Ethanol intake escalated over the first 5 to 6 drinking sessions,
and rats reached a stable consumption of ethanol by session 14.
(N=30) (B) The antinociceptive effect of DAMGO (1 nmole, i.t.) was
tested after 4 and 8 weeks of ethanol or water only drinking. After 8
weeks of ethanol consumption, rats were tolerant to the antinocicep-
tive effects of DAMGO (N=8 for both water and ethanol drinking
groups. **p,0.01; ethanol vs. water drinking group).
doi:10.1371/journal.pone.0019372.g001
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ethanol drinking rats. [
3H]DAMGO binding in the spinal cord
and several brain regions was assessed. There was no difference in
receptor density between the water and ethanol drinking rats in
any of the brain regions examined (Figure 2A, B). However,
somewhat surprisingly, we observed an increase rather than a
decrease in MOR number in the spinal cord of ethanol drinking
rats relative to the water drinking group despite the fact that i.t.
DAMGO produced less antinociception in the ethanol drinking
rats (Figure 1). Hence, it is unlikely that tolerance to the
antinociceptive effects of opioids after chronic drinking is due to
downregulation of MOR.
Ethanol drinking alters the trafficking of the MOR
As mentioned above, we have previously observed that failure to
endocytose the MOR can promote antinociceptive tolerance [35]
and see Figure S1A). Thus, we investigated whether ethanol
promoted antinociceptive tolerance to opioids by altering the
ability of the MOR to endocytose in response to opioid peptide
(Figure 3). As expected, DAMGO, but not morphine, adminis-
tered i.t. promoted endocytosis of the MOR in the spinal cord of
rats drinking only water (Figure 3B,C), consistent with previous
findings [36,37]. These endocytosed MORs co-localized with
Rab5, a marker of early endosomes (Figure 3F). However, in the
rats that had been drinking ethanol for 8 weeks, not only morphine
(data not shown), but also DAMGO, failed to promote endocytosis
of the MOR (Figure 3E), which was confirmed by a lack of MOR
and Rab5 co-localization after DAMGO treatment in rats
drinking ethanol. (Figure 3F, and see Figure S2 for additional z-
stacks). Together, these results suggest that chronic ethanol
drinking alters the ability of MOR to endocytose in response to
opioid peptides.
Chronic drinking causes downregulation of GRK2
We next examined the possible mechanisms by which chronic
drinking caused decreased DAMGO-induced MOR endocytosis.
Endocytosis of the MOR in response to agonist is initiated by
phosphorylation of the receptor by members of the GRK family
kinases. This is likely a rate limiting step, since over-expression of
GRK, and in particular GRK2, can promote MOR endocytosis
even to morphine [38,39]. We found that the levels of GRK2
protein in the spinal cord of the rats who had been drinking
ethanol for 8 weeks was significantly lower than that in the water
drinking rats (Figure 4A, B). GRK2 levels were no different in
ethanol and water drinking mice after only 4 weeks of drinking
(Figure S3). These data suggest a mechanism by which chronic
ethanol consumption can decrease endocytosis of the MOR.
Chronic ethanol consumption reduces the function of
MOR
We next assessed the functional responsiveness of MOR to
opioid in the spinal cord as well as several brain regions in rats that
had been drinking water or ethanol. Importantly, DAMGO-
activated [
35S]GTPcS binding was significantly decreased in the
spinal cord of ethanol drinking rats compared to water drinking
rats after 8 weeks of drinking (Figure 5A), even though receptor
number was not downregulated (Figure 2). In addition, a
significant reduction in DAMGO-activated [
35S]GTPcS binding
was found in the periaqueductal grey (PAG) of ethanol drinking
rats (Figure 5B). Both of these regions of the CNS are critical for
nociception. No other brain regions examined showed significant
changes in DAMGO-activated [
35S]GTPcS binding (Figure S4A).
In addition, there were no changes in DAMGO-activated
[
35S]GTPcS binding in spinal cord after only 4 weeks of drinking
(Figure S4B).
Discussion
Here we show that chronic ethanol consumption produces
antinociceptive tolerance to exogenously administered opioids. We
found that this tolerance was not accompanied by downregulation
of MOR levels [40]. Rather, we found that chronic ethanol
consumption causes a downregulation of GRK2 and thereby
significantly impedes the ability of the enkephalin DAMGO to
promote MOR endocytosis. Although many studies have clearly
demonstrated that ethanol exerts at least some of its biological
Figure 2. Comparison of MOR density in the CNS after 8 weeks
of drinking. (A) Representative autoradiograms showing [
3H]DAMGO
binding in coronal sections from water and ethanol drinking rats. (B)
Histograms show the quantification of MOR binding from different CNS
regions of ethanol and water drinking rats. Results are expressed as the
mean 6 SEM value from 3–4 rats in each group with 4–6 sections for
each rat. * p,0.05, compared with water drinking group. CC =
Cingulate cortex; Str = striatum; NAc = nucleus accumbens; Thal. =
thalamus; Amyg. = amygdala; PAG = periaqueductal gray; SC = spinal
cord.
doi:10.1371/journal.pone.0019372.g002
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primarily localized to the plasma membrane of neurons after injection of saline in rats drinking either water (A) or ethanol (D). DAMGO (B), but not
morphine (C), promoted endocytosis of the MOR in water drinking rats. (E) DAMGO did not promote endocytosis of MOR in ethanol drinking rats. The
numbers over each panel represent the average number of intracellular vesicles per neuron (n.-90 neurons per group, 2–5 rats per group) p,0.001:
i.t. DAMGO vs. all other groups (see Methods). (F) Co-immunostaining of MOR (green) and Rab5 (red) in water or ethanol drinking rats. MOR was co-
localized with Rab5 after DAMGO treatment in water drinking rats, but not in ethanol drinking rats.
doi:10.1371/journal.pone.0019372.g003
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show that voluntary ethanol drinking modulates MOR trafficking.
There is increasing evidence that receptor trafficking is a critical
process for the modulation of signal transduction from the MOR.
Ligands that promote endocytosis of the MOR have a reduced
propensity to cause antinociceptive tolerance compared to
morphine which does not [41–43] and see Figure S1A). In
addition, pharmacological [35,37,44] or genetic [45] manipula-
tions that allow morphine to promote endocytosis delay or prevent
the development of tolerance. Importantly, here we show that
chronic ethanol consumption changes trafficking of the MOR in
response to DAMGO. The rats in our study are only exposed to
DAMGO at two points: 4 weeks and 8 weeks. Hence, it is unlikely
that antinociceptive tolerance was induced by failure of MOR to
endocytose in response to DAMGO during these two exposures.
Instead, we favor the hypothesis that chronic ethanol drinking has
decreased the ability of the MOR to endocytose in response to the
endogenous endorphin and enkephalin opioid peptides. These
opioid peptides are released tonically in some circuits, but ethanol
has been shown to cause a significant increase in opioid peptide
concentration as well. Thus, we propose that chronic drinking
prevents the ability of these opioid peptides to promote receptor
Figure 4. The effect of ethanol drinking on GRK2 protein levels in rat spinal cord. After 8 weeks of drinking, GRK2 protein levels were
assessed by immunoblot in ethanol and water only drinking rats. Data are expressed as mean 6 SEM. Tissue samples were analyzed from 4 rats in
each group and three separate drinking experiments were conducted. * p,0.05, compared with the water drinking group.
doi:10.1371/journal.pone.0019372.g004
Figure 5. MOR signaling in spinal cord and PAG sections from water and ethanol drinking rats. After 8 weeks of drinking, there were
significant decreases in DAMGO-mediated [
35S]GTPcS binding in ethanol drinking compared to water drinking rats. Results are expressed as the mean
6 SEM value from 3–4 rats in each group with 4–6 sections for each rat. * p,0.05, compared with water drinking group. SC = spinal cord; PAG =
periaqueductal gray.
doi:10.1371/journal.pone.0019372.g005
Alcohol Affects Mu Opioid Receptor Trafficking
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19372endocytosis and, thereby, produces tolerance to opioids by
mechanisms similar to those produced by morphine.
Multiple mechanisms could contribute to the ability of ethanol
to prevent MOR endocytosis. Here we found that there was a
significant decrease in GRK2 protein levels in the spinal cord of
rats drinking ethanol for 8 weeks. While we can not rule out the
possibility that this is a coincidence, it is intriguing that over-
expression of GRK2 has been shown to facilitate morphine-
induced MOR endocytosis, suggesting that GRK2 is a rate
limiting step in MOR trafficking. In support of this hypothesis,
previous studies have shown that disrupting GRK2 activity
through over-expression of a dominant-negative mutant lacking
kinase activity significantly reduced MOR endocytosis promoted
by DAMGO [46] or etorphine [39] and consequently the
functional affect of opioid drugs at the MOR [47]. Thus, while
there are many ways MOR endocytosis could be adversely
affected by ethanol, we favor the hypothesis that downregulation
of key components of the endocytic machinery, or a loss of
balance in components of this machinery could contribute to this
decrease.
Failure to promote endocytosis could have varying functional
effects on receptor-mediated signal transduction. Previous studies
have found that blocking MOR endocytosis can significantly
prolong the re-sensitization process for the receptor [48], and also
promote enhanced receptor desensitization and antinociceptive
tolerance to DAMGO [49]. To examine whether drinking
promoted desensitization of the MOR, we examined the ability
of the MOR to couple to G protein. Indeed, we found that MOR
activity was significantly decreased in the ethanol drinking rats in
two areas of the CNS important for opioid-induced antinocicep-
tion: PAG and spinal cord (Figure 5A, B). Importantly, this
reduction in activity was not accompanied by a reduction in
MOR density (Figure 2). It is not clear why receptor activity
would be more affected in spinal cord and PAG compared to
other brain regions. However, chronic morphine treatment has
been shown to selectively cause MOR desensitization in spinal
cord and brain stem, but not other brain regions [50,51]. Thus,
our results are not only consistent with other reports [16–18,52],
but together our data suggest that the failure of the MOR to
endocytose in response to activation after chronic ethanol
drinking prevents the ability of the receptor to recover from
desensitization and thereby promotes behavioral antinociceptive
tolerance to opioid.
In summary, this study found that chronic alcohol intake
significantly impedes the ability of opioid peptides to endocytose
MOR, which leads to a decrease in the functional responsiveness
of MOR and behavioral antinociceptive tolerance. These results
suggest that chronic ethanol promotes adaptive changes in the
opioid system that are presumably mediated solely by the
presence of endogenous opioid. However, these results have
important implications for alcoholics, especially since the primary
therapeutic used in the treatment of alcoholism is naltrexone, an
opioid receptor antagonist. Indeed, it will be important in future
studies to examine whether similar changes in opioid receptor
signaling occur in the brain after chronic ethanol consumption as
we see in the spinal cord, since these changes this could effect
responsiveness to naltrexone treatment. In addition, our studies
suggest that higher doses of exogenous opioid drug would be
necessary to treat pain in alcoholics and perhaps even heavy
social drinkers.
Supporting Information
Figure S1 The antinociceptive effects of morphine (20
nmol/rat) or DAMGO (1 nmol/rat) following repeated
intrathecal (i.t.) drug administration and the antinoci-
ceptive effect of i.t. morphine following ethanol con-
sumption. (A) Rats were injected i.t. with either morphine (20
nmol/rat) or DAMGO (1 nmol/rat) twice daily for 5 days and the
antinociceptive effects of the drugs were measured on days 1 and
5. Rats developed significant antinociceptive tolerance to mor-
phine, but not to DAMGO. (N= 6 for both morphine and
DAMGO groups; *p, 0.05: day 5 vs. day 1) (B) Rats were tested
for i.t. morphine antinociception 4 and 8 weeks after the beginning
of ethanol drinking. The antinociceptive effect of morphine was
significantly reduced after 8 weeks of ethanol drinking compared
to water drinking group. (N=6 for both water and ethanol
drinking groups). *p, 0.05; EtOH vs. H2O drinking group).
(TIF)
Figure S2 Immunohistochemical analysis of MOR dis-
tribution 1 mm z-sections. Shown are 1 mm sections from top
to bottom of individual spinal cord neurons for each treatment
group. Pronounced MOR endocytosis was observed only in water-
drinking rats treated with i.t. DAMGO but not in the other
groups.
(TIF)
Figure S3 The effects of 4-week ethanol drinking on
GRK2 protein levels in rat spinal cord. GRK2 protein levels
were assessed by immunoblot in ethanol and water only drinking
rats. Data are expressed as mean 6 SEM. Tissue samples were
analyzed from 3 rats in each group and 4 experiments were
conducted. There was no statistically significant difference
between the two groups.
(TIF)
Figure S4 MOR signaling in several brain regions. (A)
No significant changes were observed in DAMGO-mediated
[
35S]GTPcS binding in multiple brain regions after 8 weeks of
drinking in ethanol versus water drinking rats. (B) No significant
changes were observed in DAMGO-mediated [
35S]GTPcS
binding in the spinal cord of between ethanol drinking and water
drinking rats after only 4 weeks of drinking. Results are expressed
as the mean 6 SEM value from 3-4 rats in each group with 4-6
sections for each rat. Str= striatum; NAc= nucleus accumbens;
Thal= thalamus; Amyg= amygdale.
(TIF)
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